Metropolis Unperturbed by Amazon's Diagnostics Foray

Metropolis Healthcare has made four acquisitions in recent months, and is charting out a strategy to grow its geographic presence. Ameera Shah, promoter and executive chairperson of the company, and its Managing Director Surendran Chemmenkotil, in a conversation with Sohini Das over a video interview, outline their business plans. Edited excerpts:

- 

You have made a string of acquisitions recently; what is your acquisitions strategy going ahead?

Ameera Shah: There is a funnel, and we keep evaluating and building for the future. But I don't expect anything significant for this year; I think whatever we do now will be more towards next year. We are always evaluating deals, and a lot of deals are available in the industry—some of them are integrated diagnostics, some are pure pathology. At this point, we are not clear on where we stand on high-end radiology.

With Amazon entering the segment as a tech-driven, deep-pocket competitor, what kind of dynamic changes do you see?